Thrombopoietin receptor agonists can be used temporarily with patients suffering from refractory chronic lymphocytic leukemia-associated immunologic thrombocytopenia

Leukemia and Lymphoma

Volumn 52, Issue 4, 2011, Pages 724-725

  Sinisalo, Marjatta ^a   Sankelo, Marja ^a   Itälä Remes, Maija ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; ROMIPLOSTIM; THROMBOPOIETIN RECEPTOR;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; HUMAN; MALE; PRIORITY JOURNAL; SPLENECTOMY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TOOTH EXTRACTION;

ANTINEOPLASTIC AGENTS; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; PLATELET COUNT; RECEPTORS, FC; RECEPTORS, THROMBOPOIETIN; RECOMBINANT FUSION PROTEINS; THROMBOCYTOPENIA; THROMBOPOIETIN; TREATMENT OUTCOME;

EID: 79953181294     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2010.551794     Document Type: Article

References (3)

1. Stasi R, Evangelista ML, Amadori S. Novel thrombopoietic agents: a review of their use in idiopathic thrombocytopenic purpura. Drugs 2008;68:901-912. (Pubitemid 351652920)
2. Newland A. Thrombopoietin receptor agonists in the treatment of thrombocytopenia. Curr Opin Hematol 2009;16:357-364.
3. Koehrer S, Keating MJ, Wierda WG. Eltrombopag, a second-generation thrombopoietin receptor agonist, for chronic lym-phocytic leukemia-associated ITP. Leukemia 2010;24:1096-1098.